Invest now

Niva Bupa Health Insurance Company share price

Moderate risk
  • 24%Low risk
  • 24%Moderate risk
  • 24%Balanced risk
  • 24%High risk
  • 24%Extreme risk
  • 85.98(-0.06%)
    July 21, 2026 15:24:01 PM IST
    • NSE
    • BSE
  • Vol : 292.94 K (NSE + BSE)
    Last 20 day avg : 1.72 M
Niva Bupa Health Insurance Company is trading -0.06% lower at Rs 85.98 as compared to its last closing price. Niva Bupa Health Insurance Company has been trading in the price range of 86.46 & 85.75. Niva Bupa Health Insurance Company has given 14.16% in this year & -2.28% in the last 5 days. Niva Bupa Health Insurance Company has TTM P/E ratio 96.34 as compared to the sector P/E of 12.38.There are 9 analysts who have initiated coverage on Niva Bupa Health Insurance Company. There are 3 analysts who have given it a strong buy rating & 4 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 345.13 Crores in its last quarter.Listed peers of Niva Bupa Health Insurance Company include Max Financial Services (-0.36%), Max India (-1.55%).The Mutual Fund holding in Niva Bupa Health Insurance Company was at 9.35% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Niva Bupa Health Insurance Company was at 12.09% in 30 Jun 2026. The FII holding has increased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Key Metrics

Updated on 22 Jul 2026, 01:57 AM IST

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.07
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.00
    Indicates Fair Valuation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
Price range
Day Range
Lowest
85.75
Highest
86.46
52 week range
Lowest
67.50
Highest
91.39
Niva Bupa Health Insurance Company Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Max Financial Services
1,536.70-0.3653,002.56658.4810-35.19
Max India
162.15-1.551,704.24-2.11-21.33
Mutual Fund Ownership
View all
Tata Business Cycle Fund Regular Growth
NA
  • Amount Invested (Cr.) 53.07
  • % of AUM 1.82
DSP Banking & Financial Services Fund Regular Growth
NA
  • Amount Invested (Cr.) 18.46
  • % of AUM 1.43
Tata Balanced Advantage Fund Regular Growth
3/5
  • Amount Invested (Cr.) 86.64
  • % of AUM 0.85
Tata Multi Asset Opportunities Fund Regular Growth
NA
  • Amount Invested (Cr.) 29.25
  • % of AUM 0.77
Axis Small Cap Fund Regular Growth
3/5
  • Amount Invested (Cr.) 127.80
  • % of AUM 0.51
Niva Bupa Health Insurance Company Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-05-08Audited Results
2026-01-29Quarterly Results
2025-11-03Quarterly Results
2025-07-31Quarterly Results
2025-05-07Audited Results
About the company Niva Bupa Health Insurance Company
  • IndustryInsurance (Accident & Health)
  • ISININE995S01015
  • BSE Code544286
  • NSE CodeNIVABUPA
Niva Bupa Health Insurance Company Limited is an India-based standalone health insurer (SAHI), focused on the retail health market. The Company's products are categorized into retail products, which are intended for individuals and families, and group products, which are intended for employers and employees, as well as third parties such as customers of banks and other corporate agents. Its businesses include health insurance, personal accident and travel insurance. Its health insurance business includes both indemnity-based and benefit-based health insurance products which are offered to retail and group customers. Its personal accident business includes primarily benefit-based products offered to retail and group customers. Its travel insurance business includes a combination of indemnity-based and benefit-based products, along with travel inconvenience benefits. Its travel insurance products are offered to retail and group customers, including domestic and international travelers.
  • Management Info
  • Krishnan RamachandranChief Executive Officer, Managing Director, Executive Director
  • Ankur KharbandaDeputy Chief Executive Officer, Executive Director
  • Vishwanath MahendraChief Financial Officer, Executive Director
  • Aparna SharmaCompliance Officer, Company Secretary
Niva Bupa Health Insurance Company Share Price FAQs

Niva Bupa Health Insurance Company is trading at 85.98 as on Tue Jul 21 2026 09:54:01. This is -0.06% lower as compared to its previous closing price of 86.03.

The market capitalization of Niva Bupa Health Insurance Company is 15851.86 Cr as on Tue Jul 21 2026 09:54:01.

The average broker rating on Niva Bupa Health Insurance Company is Buy. The breakup of analyst rating is given below -

  • 3 analysts have given a strong buy rating
  • 4 analysts have given a buy rating
  • 2 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Niva Bupa Health Insurance Company is 91.39 whereas the 52 wk low is 67.50

Niva Bupa Health Insurance Company can be analyzed on the following key metrics -

  • TTM P/E: 96.34
  • Sector P/E: 12.38
  • Dividend Yield: 0.00%
  • D/E ratio: 0.07

Niva Bupa Health Insurance Company reported a net profit of 130.78 Cr in 2026.

The Mutual Fund Shareholding was 9.35% at the end of 30 Jun 2026.